Yasuteru Iijima
Yasuteru Iijima publishes mostly in Molecular Biology, Pharmacology and Organic Chemistry, on topics such as Enzyme function and inhibition, Microbial Natural Products and Biosynthesis and Protein Hydrolysis and Bioactive Peptides.
- World rank
- #3,771,917 of 7,710,434 ranked researchers
- Rank in United States
- #1,040,713 of 1,627,098
- Works
- 56
- Citations
- 1.4k
- Citations per work
- 24.7
What does Yasuteru Iijima research?
Yasuteru Iijima's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Medicine (22%), Chemistry (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1934.7%
- Everything else1629.3%
- Health Sciences1222.2%
- Medicine1222.2%
- Physical Sciences813.8%
- Chemistry813.8%
- 1Molecular Biology27% of their works
- 2Pharmacology18% of their works
- 3Organic Chemistry14% of their works
- 4Oncology4% of their works
- 5Biotechnology4% of their works
- 6Biochemistry4% of their works
Research topics
- Enzyme function and inhibition
- Microbial Natural Products and Biosynthesis
- Protein Hydrolysis and Bioactive Peptides
- Phosphodiesterase function and regulation
- Cholinesterase and Neurodegenerative Diseases
- Synthesis of Organic Compounds
- Marine Sponges and Natural Products
- Carbohydrate Chemistry and Synthesis
Which keywords describe Yasuteru Iijima's research?
The keywords of their largest research topics: Drug Discovery, Anticancer Agents, Marine Natural Products, Pharmacology, Carbonic Anhydrases, Inhibitors, Natural Products and Secondary Metabolites.
- Sponge-Associated Microorganisms
- Microbial Symbionts
- cAMP Signaling
- Cyclic Nucleotide Phosphodiesterases
- Cholinesterase Inhibitors
- Antioxidant Activity
- Secondary Metabolites
- Inhibitors
- Pharmacology
- Anticancer Agents
- Drug Discovery
- Marine Natural Products
- Carbonic Anhydrases
- Natural Products
- Acetylcholinesterase
- Bioactive Peptides
- Chromones
- Flavonoids
- Glycosidase Inhibitors
- Oligosaccharide Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Drug Discovery273 topics
- Anticancer Agents192 topics
- Marine Natural Products142 topics
- Pharmacology132 topics
- Carbonic Anhydrases121 topic
- Inhibitors121 topic
- Natural Products81 topic
- Secondary Metabolites81 topic
- Acetylcholinesterase71 topic
- Antioxidant Activity71 topic
- Bioactive Peptides71 topic
- Cholinesterase Inhibitors71 topic
- Chromones71 topic
- Cyclic Nucleotide Phosphodiesterases71 topic
- Flavonoids71 topic
- cAMP Signaling71 topic
- Glycosidase Inhibitors61 topic
- Microbial Symbionts61 topic
- Oligosaccharide Synthesis61 topic
- Sponge-Associated Microorganisms61 topic
Where does Yasuteru Iijima work?
Yasuteru Iijima's main affiliation in the publication record is Biomedical Research Laboratories (United States), United States.
How many publications and citations does Yasuteru Iijima have?
OpenAlex counts 56 works and 1,383 citations for Yasuteru Iijima, an h-index of 21, ranking #3,771,917 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yasuteru Iijima. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.